Atlas FDA

ONYX LIQUID EMBOLIC SYSTEM

FDA premarket approval P030004/S006 · decided 2014-05-27

Approval details

PMA number
P030004
Supplement
S006
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
ONYX LIQUID EMBOLIC SYSTEM
Generic name
Agent, injectable, embolic
Applicant
Ev3 Neurovascular
Date received
2013-04-22
Decision date
2014-05-27
Days to decision
400 days
Decision code
APPR
Product code
MFE
Advisory committee
Neurology
Expedited review
No
Location
Irvine, CA
Statement
APPROVAL FOR THE APOLLO ONYX DELIVERY MICRO CATHETER THAT WILL BE MANUFACTURED AT MICRO THERAPEUTICS, INC. D/B/A EV3 NEUROVASCULAR IN IRVINE, CALIFORNIA.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
MERIDIAN GUIDEWIRE (K093681)Ev3 Neurovascular2010-01-26
HYPERGLIDE OCCLUSION BALLOON SYSTEM, HYPERFORM OCCLUSION BALLOON SYSTEM, MODEL 104-4112, 104-4113, 104-4127,104-4132,104 (K091458)Ev3 Neurovascular2009-10-15
HYPERGLIDE OCCLUSION BALLOON SYSTEM, MODEL 104-4310, 104-4315 (K092495)Ev3 Neurovascular2009-09-22